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Abstract
The Adaptor Protein (AP)-3 complex is an evolutionary conserved, molecular sorting device
that mediates the intracellular trafficking of proteins to lysosomes and related organelles.
Genetic defects in AP-3 subunits lead to impaired biogenesis of lysosome-related organ-
elles (LROs) such as mammalian melanosomes and insect eye pigment granules. In this
work, we have performed a forward screening for genetic modifiers of AP-3 function in the
fruit fly, Drosophila melanogaster. Specifically, we have tested collections of large multi-
gene deletions–which together covered most of the autosomal chromosomes–to identify
chromosomal regions that, when deleted in single copy, enhanced or ameliorated the eye
pigmentation phenotype of two independent AP-3 subunit mutants. Fine-mapping led us to
define two non-overlapping, relatively small critical regions within fly chromosome 3. The
first critical region included the Atg2 gene, which encodes a conserved protein involved in
autophagy. Loss of one functional copy of Atg2 ameliorated the pigmentation defects of
mutants in AP-3 subunits as well as in two other genes previously implicated in LRO biogen-
esis, namely Blos1 and lightoid, and even increased the eye pigment content of wild-type
flies. The second critical region included the ArfGAP1 gene, which encodes a conserved
GTPase-activating protein with specificity towards GTPases of the Arf family. Loss of a sin-
gle functional copy of the ArfGAP1 gene ameliorated the pigmentation phenotype of AP-3
mutants but did not to modify the eye pigmentation of wild-type flies or mutants in Blos1 or
lightoid. Strikingly, loss of the second functional copy of the gene did not modify the pheno-
type of AP-3 mutants any further but elicited early lethality in males and abnormal eye mor-
phology when combined with mutations in Blos1 and lightoid, respectively. These results
provide genetic evidence for new functional links connecting the machinery for biogenesis
of LROs with molecules implicated in autophagy and small GTPase regulation.
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Introduction
The Adaptor Protein (AP)-3 complex is a component of the basic molecular machinery that
mediates the trafficking of integral membrane proteins within the endosomal-lysosomal sys-
tem [1]. It belongs to a family of heterotetrameric complexes, AP-1 through -5 and COPI-F,
which originated through gene duplication events that took place before divergence of the last
common ancestor of all modern eukaryotes [2]. The AP-3 complex, which is considered the
most ancient of the five AP complexes [2], is composed of δ, β3, μ3 and σ3 subunits [1,3]. In
mammals, each the β3, μ3 and σ3 subunits is encoded by a pair of paralog genes. Mutations in
the gene encoding one of the two variants of the β3 subunit in humans cause Hermansky-
Pudlak syndrome (HPS) type 2 [4–11]. Like all other forms of autosomal-recessive HPS, HPS
type 2 is characterized by clinical manifestations that originate from defective formation of
cell-type-specific, and functionally specialized, lysosome-related organelles (LROs). Thus, all
forms of HPS are associated with oculocutaneous albinism and bleeding diathesis owing to
abnormal biogenesis of melanosomes and platelet dense granules, respectively [12]. In addi-
tion, patients suffering from HPS type 2 are prone to recurrent infections owing to defective
LROs in various cells of the innate immune systems [5–11].
Mechanistically, the AP-3 functions as a ‘sorting device’ that, upon recruitment to endoso-
mal membranes from a soluble cytoplasmic pool, recognizes targeting determinants within the
cytoplasmic aspect of integral membrane proteins [13]. This molecular interaction results in
the incorporation of ‘cargo’ integral membrane proteins into membrane-bounded carriers,
which are formed through membrane budding driven by assembly of AP-3 with other cytosolic
factors into a protein coat [3,13–15]. The target organelles of this AP-3-dependent trafficking
pathway, identified mainly through analyses of AP-3-deficient cells derived from HPS-2
patients and mouse models, turned out to depend on cell type [1,15]. For example, in fibro-
blasts and other mammalian cell types lacking LROs, AP-3 mediates delivery of integral mem-
brane proteins to lysosomes [4,5,16–19], while in melanocytes it defines a route for the delivery
of melanin-synthesizing enzymes to maturing melanosomes [20–22].
Several of the factors that cooperate with AP-3 in the trafficking of integral membrane pro-
teins to lysosomes or LROs have been identified through protein-protein interaction analyses,
either targeted towards candidates based on prior biological evidence or unbiased proteomic
methods [23–28]. While successful, such approach is intrinsically limited to proteins that inter-
act directly with AP-3 or indirectly through other components of the interaction network.
Alternative approaches, such as those based on the analysis of genetic interactions, may
uncover functional relationships–within the AP-3-dependent trafficking pathway or with
other cellular activities–regardless of the existence or absence of direct physical interactions.
However, few non-additive genetic interactions involving the AP-3 complex have been
reported in metazoans. In mice, phenotypic enhancement effects were observed for homozy-
gous double mutant mice deficient in AP-3 and each of three protein complexes named Bio-
genesis of Lysosome-related Organelles Complex (BLOC)-1 through -3 [26,29,30], which like
AP-3 are involved in the biogenesis of LROs and associated with various forms of human HPS
[12], as well as in double mutant mice deficient in AP-3 and OCA2 [31], with the latter being
the product of the gene mutated in oculocutaneous albinism type 2 [32]. Understandably, these
genetic interaction studies were limited to targeted approaches owing to the practical limita-
tions of inter-breeding multiple mouse lines. Phenotypic enhancement (possibly additive)
effects have also been observed in the worm, Caenorhabditis elegans [33–36], and the fruit fly,
Drosophila melanogaster [37–39], through targeted analyses of double mutants deficient in the
AP-3 complex and other factors previously implicated in LRO biogenesis. Additional targeted
approaches have led to the observations of synthetic lethality in double-mutant worms lacking
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AP-3 and the endocytic protein Disabled [40] as well as non-additive phenotypic enhancement
effects in AP-3-deficient flies carrying a weak allele of white (w) [41] or misexpressing the
endocytic protein Auxilin [39]. Finally, AP-3 mutant alleles have been identified as genetic
modifiers of morphological phenotypes induced by misexpression in flies of Blue Cheese [42],
which is a protein involved in selective disposal of ubiquitinated protein aggregates [43], the E3
ubiquitin ligase Deltex [44], and human β-amyloid peptide [45].
In this paper, we systematically searched for genetic modifiers of AP-3 function in the fly
eye. Prior to the demonstration that mutations in genes encoding AP-3 subunits cause HPS-2
in humans [4] and related phenotypes in mouse models [17,46,47], the Drosophila gene garnet
(g) had been shown to encode the fly counterpart of the δ subunit of AP-3 and to be required
for normal biogenesis of eye pigment granules [48,49], which like mammalian melanosomes
are LROs [50]. Using a hypomorphic allele of this gene for screening, we have identified dis-
tinct chromosomal regions on chromosome 3, containing the genes Atg2 and ArfGAP1, which
upon gene dosage reduction ameliorated the eye pigmentation phenotype caused by AP-3 defi-
ciency. To our knowledge, this is the first report of an unbiased, forward screening for genetic
modifiers of AP-3 function.
Materials and Methods
Fly strains and collections
Flies were raised at 25°C using standard husbandry procedures [51]. The fly line g2, which was
derived by multiple outcrosses of the triple mutant strain y1 wy2 g2 (from the Bloomington
Drosophila Stock Center) into the genetic background of Canton-S, was kindly provided by
Dr. David E. Krantz (University of California, Los Angeles, CA, USA). The fly strain Arf-
GAP1G3-85 (formerly Gap69CG3-85) was kindly provided by Dr. Vladimir E. Alatortsev (Russian
Academy of Sciences, Moscow, Russia) [52]. The mutant fly line blos1ex2 had been generated in
our laboratory [39]. All other fly strains, including Canton-S (used as ‘wild-type’ control), eyg1,
ltd1, and those of the “classic” Bloomington Deficiency Kit for chromosomes 2 and 3 and the
Bloomington Deficiency Kit of molecularly defined deletions for chromosome 4 [53], were
obtained from the Bloomington Drosophila Stock Center.
Fly eye microscopy and imaging
Fly eyes were visualized on live adults anesthetized with CO2 using a Zeiss Stemi 2000-C Stereo
microscope (Carl Zeiss, Thornwood, NY, USA). Images were acquired using a Nikon Coolpix
P5000 digital camera adapted to the same microscope.
Quantification of eye pigments
Red (pteridines) and brown (ommochromes) pigments were extracted from pooled heads of
four (for red pigments) or eight (for brown pigments) male flies at ~3 days after eclosion
(range 2–5 days) and quantified as previously described [38]. In each experiment, pigment con-
tent values were normalized to those of White-null (w1118) flies and wild-type (Canton-S) flies,
which were quantified in parallel (2–3 biological replicates per experiment) and served as 0%
and 100% controls, respectively.
Statistical analyses
Statistical analyses were performed using GraphPad Prism 5.0b (GraphPad Software, San
Diego, CA, USA). Comparisons between more than two groups of data were carried out using
one-way ANOVA followed by either Dunnett’s (for comparison of multiple data groups to a
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single common control) or Bonferroni’s (for comparison of selected pairs of data groups within
a multiple comparison analysis) post-hoc tests, as indicated in each figure or table legend.
Results and Discussion
Primary and secondary screening for genomic regions carrying
modifiers of AP-3 function
In order to identify regions within the autosomal chromosomes of D.melanogaster (chromo-
somes 2, 3 and 4) potentially bearing genes that, when in hemizygous form due to deletion of
one copy, modify the severity of the phenotype of AP-3-mutant flies, a genetic screening was
undertaken following the strategy depicted in Fig 1. In both primary (qualitative) and second-
ary (quantitative) steps of the screening, male flies carrying large multi-gene deletions (‘defi-
ciencies’) from the so-called ‘Bloomington Deficiency Kit’ collections were crossed with female
flies homozygous for the g2mutation (on chromosome X) to obtain F1 males that were hemizy-
gous for g2 and heterozygous for a given deficiency over a normal chromosome; for each defi-
ciency, the eye color of these F1 males was compared to that of control g
2 males first by light
microscopy and, if selected for secondary screening, by pigment extraction and quantification
(Fig 1). The g2 mutation in the gene encoding the δ subunit of AP-3 was chosen not only
because of its genomic location on the X chromosome (thus minimizing the number of genetic
crosses required to test each deficiency) but also because it represents a weak hypomorph of
the garnet allelic series [54]. In our hands, the eyes of male adult flies carrying the g2 allele in
the Canton-S genetic background contain 25–30% of the red pigment content of those of the
control Canton-S line, whereas those of males carrying one of the strongest alleles of the same
gene, g53d, contain less than 5% of wild-type levels of red pigments (see, for example, Ref. [39]).
Thus, the g2 line was used as a sensitized strain with which both phenotypic enhancers and sup-
pressors could potentially be identified.
Out of 213 deficiency lines screened, which together covered>92% of fly autosomal chro-
mosomes 2–4, twenty were selected for secondary screening on the basis of apparent differ-
ences in eye color of the corresponding F1 males (g
2 hemizygous carrying a copy of the
deficiency) relative to g2 males upon visualization under a dissecting microscope. Of these
twenty candidates, seven resulted in statistically significant changes in red pigment levels, upon
correction for multiple testing, with all of these changes representing increased pigment con-
tent in the eyes of the corresponding F1 males relative to those of g
2 controls (Fig 2). It is possi-
ble that some of the remaining candidate deficiencies might have modified the eye color
phenotype of g2mutants through quantitative changes in brown pigment levels only. Neverthe-
less, given that our goal was to identify modifier genes that might act at the level of pigment
granule biogenesis and/or dynamics, thus affecting the accumulation of both pigment types in
these granules, those candidate deficiencies that failed to elicit significant changes in red pig-
ment content were not characterized any further. In addition, one of the seven candidates
resulting in statistically significant differences, Df(2R)PC4, was excluded from further analysis
because the relative increase in red pigment content was less than a threshold of 50% increase,
which we had arbitrarily set to focus our efforts on the most promising candidates (Fig 2).
The six selected deficiencies were then tested for their ability to modify, when carried in sin-
gle copy, the brown pigment content of g2 flies (to verify that both pigment types, not just red
pigments, were affected) as well as the red pigment content of rb1 flies (which carry a hypo-
morphic mutation in the gene encoding the β3 subunit of AP-3 [55,56]) and wild-type (Can-
ton-S) flies. The results of these experiments are listed in Table 1. Upon correction for multiple
testing, the statistical analyses suggested that: (i) each of the six deficiencies modified the pig-
mentation phenotype of an independent AP-3 mutant (rb1); (ii) four of them also altered the
Genetic Modifiers of AP-3 Function in Flies
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Fig 1. Strategy for the genetic modifier screening carried out in this study. The primary screening involved parental (P0) crosses between male flies
carrying a deficiency (Df) over a balancer in an autosomal chromosome (Chr. 2, 3 or 4) and female flies homozygous for the hypomorphic g2 allele of the X-
linked gene encoding the δ subunit of AP-3. The eye color of male progeny (F1) carrying one copy of each deficiency (without the balancer) was compared
with that of control g2males and, if deemed different, the corresponding deficiency was selected for a secondary screening involving the same P0 cross
followed by quantification of red and brown pigments in the F1 males carrying the deficiency. In cases in which differences in both red and brown pigment
content were statistically significant, further validation and fine mapping was attempted using independent deficiency lines in which the deleted genomic
regions partially overlapped with that of the deficiency identified through screening. When successful, theses steps allowed identification of a relatively small
genomic region (rectangle) containing a modifier gene of interest (red arrow).
doi:10.1371/journal.pone.0143026.g001
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Fig 2. Red pigment content in eyes of g2mutant flies carrying hemizygous deletions selected through
primary screening.Red pigments were extracted from the heads of adult g2mutant males carrying no
deletions (—) or a single copy of the indicated deficiencies, quantified as described under Materials and
Methods, and expressed as percentages of the red pigment content of male flies of the wild-type line
(Canton-S). Bars represent means + SD of 2–28 biological replicates. Grey bars denote values obtained for
flies carrying the marker allelew+mC linked to the deficiency. Dashed lines indicate threshold values
corresponding to 66.7% (2/3) and 150% (3/2) of the pigment content of control g2 flies carrying no deletion
(black bar). One-way ANOVA followed by Dunnett’s test of each group versus g2 flies carrying no deletion:
***p<0.001.
doi:10.1371/journal.pone.0143026.g002
Genetic Modifiers of AP-3 Function in Flies
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red pigment levels of wild-type flies; and (iii) all but one, Df(2R)CD21, modified the brown pig-
ments levels of g2 flies (Table 1) in addition to modifying their red pigment content (Fig 2).
Together, the primary and secondary screening yielded one genomic region on chromosome 2,
which is deleted in deficiency Df(2L)XE-3801, and four independent genomic regions on chro-
mosome 3, which are deleted in deficiencies Df(3L)eygC1, Df(3R)Exel6195, Df(3L)ED4978, and
Df(3L)BSC23, for validation and further characterization.
Attempts to validate candidate genomic regions deleted in deficiencies
carrying the marker ‘mini-white’
Three of the five deficiencies selected for validation, namely Df(2L)XE-3801, Df(3R)Exel6195,
and Df(3L)ED4978, carried the constructmini-white (w+mC) as a genetic marker. It is well
known that expression of this construct, which represents a truncated version of the w gene
lacking some regulatory sequences, varies significantly depending upon the site of chromo-
somal insertion [57]. Given that high levels of White protein overexpression had been reported
to increase, albeit modestly, eye pigmentation of AP-3 δmutants [41], the possibility of ‘false-
positive’ hits in our screening owing to high expression of the w+mC construct deserved consid-
eration. To begin to address this issue, genetic crosses were set up to generate male flies hemi-
zygous for the White-null allele w1118 (on chromosome X) and heterozygous for each of the
three deficiencies; in these flies, White function derived exclusively from expression of the
w+mC construct. As shown in Fig 3A (arrow), the w+mC construct carried by one of the three
deficiencies, Df(3L)ED4978, on a White-null background resulted in red pigment levels of
almost 40% of wild-type levels. In further support of the notion that deficiency Df(3L)ED4978
might have represented a false-positive hit in our screening, none of two ‘overlapping’ deficien-
cies–with deletions that together covered the entire region deleted in Df(3L)ED4978 –modified
the eye pigmentation phenotype of g2 flies (Fig 3B). Although the w+mC construct carried by
the other two deficiencies, Df(2L)XE-3801 and Df(3R)Exel6195, resulted in very little pigmenta-
tion on aWhite-null background (Fig 3A), attempts to validate their phenotypic modifier effect
observed on the g2 background, using independent overlapping deficiencies, were nonetheless
Table 1. Pigment content in flies carrying deficiencies in different genetic backgrounds.
Deficiency Brown pigment Red pigment
g2 background rb1 background Canton-S background
— 61.8 ± 2.8 (5) 16.5 ± 1.7 (12) 100 ± 8 (3)
Df(3L)eygC1 68.5 ± 3.7 (4)* 33.7 ± 3.4 (6)*** 120 ± 8 (5)NS
Df(2R)CB21 65.0 ± 4.8 (4)NS 26.1 ± 2.0 (8)*** 121 ± 13 (4)NS
Df(3R)Exel6195 75.3 ± 1.2 (3) *** 31.0 ± 2.3 (7)*** 131 ± 12 (4)**
Df(3L)ED4978 74.3 ± 1.2 (3)*** 32.0 ± 3.7 (5)*** 128 ± 12 (4)*
Df(2L)XE-3801 68.8 ± 2.1 (3)* 34.3 ± 3.4 (6)*** 123 ± 12 (5)*
Df(3L)BSC23 78.3 ± 4.5 (3)*** 39.2 ± 0.8 (5)*** 132 ± 12 (9)**
Brown or red pigment content in the eyes of adult male flies carrying no deletions (—) or a single copy for each of the indicated deficiencies was
measured as described under Materials and Methods and expressed as a percentage of the corresponding pigment content in the eyes of adult male flies
of the control line Canton-S. Values represent means ± SD of the numbers of biological replicates indicated between parentheses. One-way ANOVA
followed by Dunnett’s test of each group versus the corresponding control carrying no deficiency in the same background: NS, not significant
*p<0.05
**p<0.01
***p<0.001.
doi:10.1371/journal.pone.0143026.t001
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Fig 3. Attempts to validate selected deficiencies carrying thew+mCmarker as genetic modifiers of the g2mutation. (A) Red pigments were extracted
from the heads of AP-3-deficient (g2) or White-negative (w1118) adult males carrying single copies of the indicated deficiencies with their associatedw+mC
marker. The extracted pigments were quantified as described under Materials and Methods, and the resulting values expressed as percentages of the
pigment content of wild-type (Canton-S) flies. Bars represent means + SD of 2–10 biological replicates. Notice that the activity of thew+mCmarker associated
with deficiency Df(3L)ED4978 resulted in a red pigment content (arrow) higher than that of g2 flies (black bar). (B-D) Analyses of red pigment content in the
eyes of adult g2mutant males carrying no deletions (—), single copies of the deficienciesDf(3L)ED4978 (B), Df(3R)Exel6195 (C) and Df(2L)XE-3801 (D) that
had been identified through screening, or single copies of deficiencies with partially overlapping deletions and devoid of thew+mCmarker. Schematic
representations of the extent of overlap between the chromosomal regions deleted in the deficiencies identified through screening (blue) and the others
(grey) are included in each figure panel. Notice in (C) that a small portion of the chromosomal region deleted in Df(3R)Exel6195 (dashed box) did not overlap
with any of those deleted in other available deficiencies. One-way ANOVA followed by Dunnett’s test of each group versus control g2 flies carrying no
deletion (black bars): **p<0.01; ***p<0.001.
doi:10.1371/journal.pone.0143026.g003
Genetic Modifiers of AP-3 Function in Flies
PLOS ONE | DOI:10.1371/journal.pone.0143026 November 13, 2015 8 / 23
unsuccessful (Fig 3C and 3D). It should be noted, however, that the deficiencies available for
validation did not completely cover the genomic region deleted in Df(3R)Exel6195, thus leaving
open the possibility that the partial phenotypic suppression effect elicited by this deficiency
could have been caused by hemizygous deletion of a gene in the region that was not deleted in
any of the other deficiencies tested (Fig 3C, dashed rectangle). Interestingly, this region turned
out to contain a single gene, CG31145, which was reported to encode a Golgi-localized protein
with casein-kinase activity [58]. Further investigation will be required to test the possibility of
CG31145 being a genetic modifier of AP-3 function in the fly eye.
Validation and fine-mapping of the genomic regions responsible for the
modifier effects elicited by Df(3L)eygC1 and Df(3L)BSC23
The partial suppressor effects elicited by deficiencies Df(3L)eygC1 and Df(3L)BSC23 on the eye
pigmentation phenotype of AP-3-mutant flies could be successfully validated by independent
deficiencies with partially overlapping deletions.
In the case of Df(3L)eygC1, four independent deficiencies were available to cover the entire
genomic region deleted in the original deficiency, and two of them elicited partial suppressor
effects on the phenotype of g2 flies that were akin to that observed for Df(3L)eygC1 (Fig 4).
Although one of these two deficiencies, Df(3L)ED4483, carried the w+mC construct as a marker,
expression of this construct was deemed low on the basis of the red pigment content of flies
carrying such deficiency on a White-null background (Fig 3A). Through comparison of the
genomic regions deleted in the deficiencies that elicited the modifier effect and those that failed
to do so, a critical region comprising 17 annotated genes was defined (Fig 4, bottom box).
In the case of Df(3L)BSC23, seven independent deficiencies were available to cover the entire
genomic region deleted in the original deficiency; three of them carried the w+mC construct
(Fig 5), with expression levels that were deemed low to moderate on the basis of pigmentation
of flies carrying them on a White-null background (Fig 3A). When assessed for their ability to
modify the phenotype of g2 flies, only one overlapping deficiency carrying a ‘weak’ w+mC con-
struct, Df(3L)Exel6091, and one deficiency lacking w+mC, Df(3L)BSC119, elicited a partial sup-
pressor effect similar to that observed for the original deficiency (Fig 5). Through analysis of
the genomic regions deleted in these deficiencies, a critical region encompassing six annotated
genes was defined (Fig 5, left bottom box).
Practical limitations precluded a systematic investigation of each of the genes included in
the critical regions derived from Df(3L)eygC1 and Df(3L)BSC23. These limitations were: the
very limited availability of loss-of-function alleles of single genes, and the inconsistency of
results that we obtained using available RNAi transgenes (expressed with the aid of a
GMR-GAL4 driver [39]), with the latter likely arising from off-target effects [59]. For this rea-
son, a candidate-gene approach was undertaken, as described in the following sections.
Atg2 as a genetic modifier of fly eye pigmentation
An obvious candidate out of the six genes located within the critical region derived from Df
(3L)BSC23 was Atg2, which encodes a conserved protein involved in autophagy [60]. Genetic
links between autophagy and pigmentation defects had been previously described in mammals
[61] and flies [62], though none of them involved Atg2 in particular. A loss-of-function allele
of this gene, Atg2EP3697, had been previously validated in assays of autophagy function in the
larval fat body [63,64]. Homozygous Atg2EP3697 flies die before reaching adulthood [60],
whereas heterozygotes are viable with no apparent eye morphological phenotypes. Although
the Atg2EP3697 allele carries a copy of the w+mC construct, its expression was deemed to be quite
Genetic Modifiers of AP-3 Function in Flies
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Fig 4. Validation and fine mapping of the critical region responsible for the modifier effect observed forDf(3L)eygC1. Red pigments were extracted
from the heads of adult g2mutant males carrying no deletions (—) or a single copy of the indicated deficiencies, quantified as described under Materials and
Genetic Modifiers of AP-3 Function in Flies
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low on the basis of the red pigment content of White-null flies carrying one copy of the allele
(Fig 6).
Satisfyingly, a single copy of the Atg2EP3697 allele (in heterozygous form over a normal third
chromosome) elicited statistically significant increases in the eye pigment levels of the AP-3
mutants g2 and rb1 (Fig 6). A single copy of the same allele also increased the red pigment con-
tent of Canton-S flies (Fig 6), an effect which was in line with that originally observed for the
Df(3L)BSC23 deficiency (Table 1). In these three genetic backgrounds, the effect of the
Atg2EP3697 allele on eye pigmentation was less pronounced than that observed for Df(3L)
BSC23; we speculate that either Atg2EP3697 might not represent a true null allele of this gene or
that other genes within the critical region might have contributed to the effect observed for the
deficiency.
Next, we tested for effects of the Atg2EP3697 allele on the phenotypes of another two mutants
of the pigment granule group, namely blos1ex2 and ltd1. The blos1 gene encodes a subunit of the
fly counterpart of mammalian BLOC-1 [39,65], which like AP-3 is involved in intracellular
protein trafficking and the biogenesis of LROs [22,25,26,66–68]. Although the two complexes
have been shown to interact physically with each other [25–27,69–71], epistatic analyses in
mice and flies have suggested that BLOC-1 and AP-3 can function, at least in part, indepen-
dently of each other [26,30,39]. The lightoid (ltd) gene encodes the single fly counterpart of two
closely related mammalian GTPases of the Rab family, named Rab32 and Rab38; both mam-
malian proteins as well as the Lightoid protein are involved in the biogenesis of LROs [37,72–
74]. While mammalian Rab32 and Rab38 have been shown to interact physically and function-
ally with AP-3 [28], epistatic analyses have suggested that fly Lightoid and AP-3 can function,
at least in part, independently of each other [37]. As shown in Fig 6, a single copy of the
Atg2EP3697 allele elicited small but statistically significant increases in the eye pigment contents
of homozygous blos1ex2 and ltd1 mutants.
Together, these results suggest that the gene dosage of Atg2 influences the eye pigmentation
phenotype of AP-3 mutants as well as of other mutations affecting pigment granule biogenesis.
Because the eye pigmentation of wild-type flies was likewise modified, it is tempting to specu-
late that the product of Atg2may influence pigmentation by a mechanism distinct from those
mediated by AP-3, BLOC-1 and Lightoid. Thus, one may envision that autophagy–at least a
form of it that it is sensitive to partial reductions in Atg2 activity–could be involved in the turn-
over of pigment granules. In such a scenario, decreased pigment granule degradation in
Atg2EP3697 heterozygotes would explain the increase in eye pigment content observed for all of
the genetic backgrounds tested. Furthermore, the extent of pigment content increase could
depend on how impaired autophagy of these granules might be in Atg2EP3697 heterozygotes as
well as on the rate of pigment granule turnover in the different genetic backgrounds (e.g.,
abnormal pigment granules in mutant flies might be targeted for degradation at a rate higher
than that of normal granules in wild-type flies). Although the notion of organelle turnover by
autophagy is widely accepted, and extensively documented for compartments such as mito-
chondria or peroxisomes [75], evidence for a direct role of autophagy in the degradation pig-
ment granules (or melanosomes, in mammals) remains quite limited. For example,
autophagosomes containing melanosomal proteins were observed in human melanocytes
Methods, and expressed as percentages of the red pigment content of male flies of the wild-type (Canton-S) line. Bars represent means + SD of 6–10
biological replicates. One-way ANOVA followed by Dunnett’s test of each group versus g2 flies carrying no deletion (black bar): ***p<0.001. Shown on the
left is a schematic representation of the extent of overlap between the chromosomal region deleted in the deficiency that had been identified through
screening (blue) and those deleted in independent deficiencies that elicited (red) or failed to elicit (grey) a similar modifier effect on the g2 eye color
phenotype. The critical genomic region responsible for the observed modifier effect is highlighted with black dashed lines, and the relative location of genes
found within this region (adapted from the FlyBase database) is depicted at the bottom.
doi:10.1371/journal.pone.0143026.g004
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Fig 5. Validation and fine mapping of the critical region responsible for the modifier effect observed forDf(3L)BSC23. Red pigments were extracted
from the heads of adult g2mutant males carrying no deletions (—) or a single copy of the indicated deficiencies, quantified as described under Materials and
Methods, and expressed as percentages of the red pigment content of male flies of the wild-type (Canton-S) line. Bars represent means + SD of 3–15
biological replicates. One-way ANOVA followed by Dunnett’s test of each group versus g2 flies carrying no deletion (black bar): **p<0.01, ***p<0.001.
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deficient in the HPS1 subunit of BLOC-3 [76]–a protein complex that functions in the biogene-
sis of LROs through activation of Rab32 and Rab38 [77]–and compartments described as
“autophagic melano-lysosomes” were found in retinal pigment epithelium from apparently
normal rhesus monkeys [78]. In addition, it has recently been reported that melanosomes
transferred from melanocytes to keratinocytes in human skin can be degraded by autophagy
[79]. On the other hand, published work using mammalian melanoma cell lines has uncovered
a surprising link between specific components of the machinery for autophagy and the regula-
tion of melanosome biogenesis, with some of these components promoting (e.g., the human
Atg18 homologue WIPI1 [80,81]) and others antagonizing (e.g., the human Atg1 homologue
ULK1 [82]) melanin accumulation in cell culture. Given this reported link between autophagy
and the biogenesis of mammalian melanosomes, a putative role for Atg2 in the regulation of fly
pigment granule biogenesis should be considered.
From a genetic perspective, two aspects of the identification of Atg2 in our genetic modifier
screening are worth noting. First, so far genetic defects in autophagy-related genes in humans
or mice have been associated with reduced pigmentation [80,83,84], not with increased pig-
ment content. Second, it is not clear why out of the large number of known autophagy-related
genes [60] only Atg2 was isolated in a screening designed to cover>92% of fly autosomal chro-
mosomes (a small subset of these genes, including Atg5 and Atg8a, were excluded from the
screening because of their localization to fly chromosome X). Plausible explanations include
genetic redundancy among groups of paralogs with partially overlapping functions, as it might
be the case for the related Atg18a and Atg18b genes encoding alternative binding partners of
Atg2 [64], and gene dosage sensitivity, i.e., loss of one of the two copies of a gene may not nec-
essarily translate into significantly decreased physiological function of the gene product. These
issues notwithstanding, the possibility of the Atg2 protein playing a specific function related to
pigment granule dynamics (biogenesis or degradation), besides its role as a core component of
the autophagy machinery [60], should deserve consideration for future studies.
ArfGAP1 as a dominant genetic modifier of AP-3 mutants
Two genes within the critical region inferred for the Df(3L)eygC1 deficiency (Fig 4) and with
available loss-of-function alleles were considered as candidates of interest. The first candidate
was eyegone (eyg), which encodes a member of the Pax6 family of transcription factors involved
in retina development [85]. While the eyes of homozygous eyg1 mutants are drastically reduced
in size [85], heterozygous mutants display apparently normal eye morphology. In contrast with
the Df(3L)eygC1 deficiency, however, a single copy of the eyg1 allele failed to modify the eye pig-
mentation phenotype of g2 mutants. Thus, the red pigment contents (expressed as percentage
of wild-type levels) were 29.5 ± 2.1 for g2 and 30.0 ± 3.4 for g2;eyg1/+ (means ± SD; n = 6 and 9
respectively). In light of this result, this candidate was not pursued any further.
The second candidate was ArfGAP1 (formerly known as Gap69C), which encodes a con-
served GTPase-activating protein (GAP) with specificity to promote hydrolysis of GTP bound
to members of the Arf protein family [52,86]. Flies carrying the null allele ArfGAP1G3-85, either
in homozygous or heterozygous form, are viable and display no eye morphological abnormali-
ties [52]. Here, a single copy of the ArfGAP1G3-85 allele elicited statistically significant increases
in the pigment contents of the AP-3 mutants g2 (Fig 7A) and rb1 (Fig 7B). On the other hand,
Shown on the left is a schematic representation of the extent of overlap between the chromosomal region deleted in the deficiency that had been identified
through screening (blue) and those deleted in independent deficiencies that elicited (red) or failed to elicit (grey) a similar modifier effect on the g2 eye color
phenotype. The critical genomic region responsible for the observed modifier effect is highlighted with black dashed lines, and the relative location of the six
genes found within this region (adapted from the FlyBase database) is depicted at the bottom.
doi:10.1371/journal.pone.0143026.g005
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Fig 6. Effects of the Atg2EP3697 allele on red pigment content in various genetic backgrounds. Red
pigments were extracted from the heads of adult male flies of the indicated genetic backgrounds lacking
(open bars) or carrying (filled bars) one copy of the Atg2EP3697 allele over a normal chromosome 3. The
extracted pigments were quantified as described under Materials and Methods, and the resulting values
expressed as percentages of the pigment content of wild-type (Canton-S) flies. Bars represent means + SD
of 7–15 biological replicates. One-way ANOVA followed by Bonferroni comparison of selected group pairs:
*p<0.05, **p<0.01, ***p<0.001. Notice that a single copy of Atg2EP3697 over a normal Atg2 allele increased
pigmentation of two AP-3-subunit mutants (g2 and rb1), a BLOC-1-subunit mutant (blos1ex2), and a mutant in
Genetic Modifiers of AP-3 Function in Flies
PLOS ONE | DOI:10.1371/journal.pone.0143026 November 13, 2015 14 / 23
and consistently with the behavior observed for the Df(3L)eygC1 deficiency (Table 1), a single
copy of the ArfGAP1G3-85 allele failed to modify the red pigment content of wild-type flies (Fig
8A). Interestingly, the modifier effect elicited by the ArfGAP1G3-85 allele in the g2 background
appeared to follow a dominant pattern. Thus, eye pigmentation increases similar to those
observed for g2 flies heterozygous for ArfGAP1G3-85 over a normal third chromosome (Fig 7A)
were observed not only for g2 flies that were heterozygous for ArfGAP1G3-85 over a control dele-
tion (referred in the figure to as ‘Df3’) but also for those that were homozygous for the Arf-
GAP1G3-85 mutation or compound heterozygous for ArfGAP1G3-85 over either of two large
deletions (‘Df1’ and ‘Df2’) encompassing the entire ArfGAP1 gene (Fig 7C).
the Rab-GTPase Lightoid (ltd1), though it also increased the red pigment content of wild-type flies. Although
the transposon inserted in Atg2EP3697 carries thew+mCmarker, its weak activity led to barely detectable red
pigments in a White-null background (w1118).
doi:10.1371/journal.pone.0143026.g006
Fig 7. ArfGAP1 as a modifier of the AP-3 eye pigmentation phenotype. (A-C) Red pigments were extracted from the heads of adult male flies of the
indicated genetic backgrounds carrying wild-type (+) or mutant (G3-85) alleles of the ArfGAP1 gene on chromosome 3. The extracted pigments were
quantified as described under Materials and Methods, and the resulting values expressed as percentages of the pigment content of wild-type (Canton-S)
flies. Bars represent means + SD of 3–17 biological replicates. Statistical analyses were performed by means of Student’s t-test (A and B) or one-way
ANOVA followed by Dunnett’s test of each group versus g2 flies carrying no deletion (C): *p<0.05, **p<0.01, ***p<0.001. Notice that a single copy of
ArfGAP1G3-85mutant allele over wild-type ArfGAP1was sufficient to ameliorate the pigmentation defects of both g2 (A) and rb1 (B) AP-3-subunit mutants.
Notice in (C) that such partial suppressor effect was not exacerbated in flies homozygous for the ArfGAP1G3-85 allele or heterozygous for this allele over any
of two deficiencies in which the deleted genomic regions include the entire ArfGAP1 gene, namely Df(3L)eygC1 (Df1) and Df(3L)BSC380 (Df2). The deficiency
Df(3L)BSC413, in which the deleting genomic region excludes the ArfGAP1 gene, was used as a control (Df3).
doi:10.1371/journal.pone.0143026.g007
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As described in the previous section for the Atg2EP3697 mutant allele, we next tested for
effects of the ArfGAP1G3-85 allele on the phenotypes of blos1ex2 and ltd1 mutants (deficient in
BLOC-1 and the Rab GTPase Lightoid, respectively). The results were remarkable. On the one
Fig 8. Homozygous ArfGAP1-null mutants display pleiotropic effects depending on genetic
background. (A-C) Genetic crosses were set up to obtain flies carrying wild-type (+) or null mutant (G3-85)
alleles of the ArfGAP1 gene in the genetic backgrounds of the wild-type line Canton-S (A), the BLOC-
1-subunit mutant blos1ex2 (B) and the Lightoid GTPase mutant ltd1 (C). Notice in (B) that males that were
double homozygous for ArfGAP1G3-85 and blos1ex2 did not survive to adulthood (indicated with X). In those
cases in which viable adult males were obtained, red pigments were extracted and quantified as described
under Materials and Methods. Values were expressed as percentages of the pigment content of wild-type
flies. Bars represent means + SD of 3–9 biological replicates. Statistical analyses were performed by means
of Student’s t-test (B) or one-way ANOVA followed by Dunnett’s test of each group versus that of flies
homozygous for the wild-type ArfGAP1 allele in the corresponding genetic background (A and C): ns, not
significant; *p<0.05, ***p<0.001. (D and E) eye morphology of adult flies homozygous for ltd1 (D) and for
both ltd1 and ArfGAP1G3-85 (E), with the latter displaying a mild interommatidial facets phenotype.
doi:10.1371/journal.pone.0143026.g008
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hand, a single copy of ArfGAP1G3-85 did not modify significantly the eye color phenotypes of
homozygous blos1ex2 and ltd1 flies (Fig 8B and 8C), suggesting that the dominant modifier
effect observed for ArfGAP1G3-85 in the genetic backgrounds of g2 (Fig 7A) and rb1 (Fig 7B)
reflected a specific functional interaction between ArfGAP1 and the AP-3 complex. On the
other hand, in homozygous form the ArfGAP1G3-85 allele caused drastic effects, namely: syn-
thetic lethality of males in the background of blos1ex2 homozygous (i.e., no doubly homozygous
males survived to adulthood), and abnormal eye morphology (i.e., disrupted organization of
interommatidial bristles) with decreased pigmentation in the background of ltd1 homozygotes
(Fig 8C–8E). These strong effects, which were also observed using compound heterozygous of
ArfGAP1G3-85 over deletions of the entire ArfGAP1 gene [using deficiencies Df(3L)BSC380 and
Df(3L)ED4483 for blos1ex2 and the former for ltd1], were at odds with those observed by Arf-
GAP1G3-85 in homozygous form in the genetic backgrounds of g2 (Fig 7C) or Canton-S (Fig
8A), where neither early lethality nor abnormal eye morphology were noted.
Taken together, the results suggest that ArfGAP1may be a dominant genetic modifier of
AP-3 function and interact genetically with blos1 or ltd in a recessive fashion. Because of the
multiple cellular functions ascribed to the conserved ArfGAP1 protein in various organisms
[86,87], several scenarios seem plausible. For example, given that the recruitment of the AP-3
complex to membranes is promoted by an Arf family member (possibly Arf1) in its GTP-
bound form [88–91], one could envision that decreased Arf GAP activity (due to reduced dos-
age of the ArfGAP1 gene) might partially compensate for incomplete impairment of AP-3
function (as in the genetic backgrounds of g2 and rb1) by slowing down inactivation of GTP-
bound Arf molecules at the site(s) of AP-3 function. While this relatively simple scenario could
explain the specificity and even the dominant pattern of the effects elicited by the ArfGAP1G3-
85 allele on AP-3 mutants, a few potential shortcomings should be noted. Firstly, at least in
mammalian cell lines the regulation of AP-3 function through inactivation of Arf-GTP has
been ascribed to a different Arf GAP, named AGAP1 [24], for which a clearly recognizable
homologue (encoded by ceng1A) exists in flies [92]. Secondly, ArfGAP1 has well-documented
activities besides inactivation of Arf GTPases, including serving as effectors of GTP-bound Arf
proteins and having Arf-independent functions [86,87]. Finally, such a simple model would
not provide a straightforward explanation for the strong genetic interactions observed for
homozygous double mutants in ArfGAP1 and either blos1 (synthetic lethality in males) or ltd
(abnormal eye morphology), as genetic interactions between AP-3 mutants and blos1 or ltd
alleles have been documented to affect eye pigment content but neither viability nor eye mor-
phology [37,39]. Along these lines, one should consider that a second Arf-dependent protein
trafficking pathway, defined by the structurally related AP-1 complex, has been implicated in
the biogenesis of mammalian melanosomes [21,22,28,93] and might be likewise operational in
the biogenesis of pigment granules in the fly eye. Accordingly, one could envision that reduced
activity of ArfGAP1, which in mammals has been shown to interact physically with AP-1 [94],
might exacerbate the activity of the AP-1-dependent pathway–at least in the context of
impaired AP-3 function. Because AP-1, unlike AP-3, is essential for Drosophila larval develop-
ment [95], invoking a putative role for ArfGAP1 in the AP-1-dependent pathway could pro-
vide possible explanations for the abnormalities observed in homozygous double mutants for
ArfGAP1 and blos1 as well as for ArfGAP1 and ltd. These considerations notwithstanding, a
scenario whereby ArfGAP1 would act on an AP-1-dependent pathway would not represent the
only plausible alternative to that of a direct role in AP-3-dependent events. For example, recent
studies have demonstrated that ArfGAP1 from mammals and flies can interact physically and
functionally with a leucine-rich repeat kinase, named LRRK2 in mammals and Lrrk in flies
[96,97], which in turn has been shown to function in the endosomal-lysosomal system and
autophagy of both flies and mammals [98–101] in part through interactions with Rab GTPases
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such as Rab7 [100] and–most notably–Lightoid and its mammalian counterparts [102,103].
Accordingly, decreased ArfGAP1 activity could have elicited the modifier effects reported in
this paper through alteration of the function of proteins such as Lrrk. Future research will be
required to test experimentally the validity of these and other plausible scenarios.
Conclusions
Our genetic modifier screening has led to the identification of distinct regions within fly chro-
mosome 3, and in particular of two candidate genes, which upon deletion or mutation in het-
erozygous form modified the eye pigmentation phenotype of AP-3 mutants. One of these
candidate genes encodes the single fly counterpart of Atg2, a conserved component of the
molecular machinery for autophagy. The other gene encodes the single fly counterpart of Arf-
GAP1, a conserved protein implicated in Arf-dependent protein trafficking events as well as in
Lrrk-dependent regulation of the endosomal-lysosomal system and autophagy.
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